ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DHT.UN DRI Healthcare Trust

11.92
0.00 (0.00%)
30 Jul 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
DRI Healthcare Trust TSX:DHT.UN Toronto Trust
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 11.92 11.79 11.79 0 12:25:51

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

04/08/2022 6:06pm

PR Newswire (Canada)


DRI Healthcare (TSX:DHT.UN)
Historical Stock Chart


From Jul 2022 to Jul 2024

Click Here for more DRI Healthcare Charts.

TORONTO, Aug. 4, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that the Trust will participate in the following investor conferences in August and September:

Canaccord Genuity Annual Growth Conference

Date: August 10, 2022 
Presentation time: 9:00 am ET
City: Boston, Massachusetts
Event URL:  https://www.canaccordgenuity.com/capital-markets/about-us/events/42nd-annual-growth-conference/

CIBC Eastern Institutional Investor Conference

Date: September 21, 2022
Presentation time: TBD
City: Montreal, Quebec

About DRI Healthcare Trust

DRI Healthcare Trust provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Our business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties with the aim to deliver attractive growth in cash royalty receipts over the long-term. DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario, externally managed by its manager, DRI Capital Inc., a pioneer in global pharmaceutical royalty monetization. Throughout its history, DRI Capital has provided capital to biopharma innovators, including inventors, institutions, and biopharma companies, building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world, acquiring dependable, patent-protected cash flow streams derived from the sales of those important drugs. Active across a broad range of therapeutic areas, DRI Capital has deployed more than $2 billion, acquiring more than 60 royalties on 40-plus drugs, including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara. DRI Healthcare Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in U.S. dollars under the symbol "DHT.U". To learn more visit drihealthcaretrust.com.

SOURCE DRI Healthcare Trust

Copyright 2022 Canada NewsWire

1 Year DRI Healthcare Chart

1 Year DRI Healthcare Chart

1 Month DRI Healthcare Chart

1 Month DRI Healthcare Chart

Your Recent History

Delayed Upgrade Clock